HYOU1 and cancer: To test whether Flagrp170 can improve the therapeutic outcome of vaccination against cancer metastases, we established experimental lung metastases through the i.v. injection of B16 tumor cells, followed by treatment with a Flagrp170 or Grp170-based chaperone vaccine.